RxSight, Inc.
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale countsTransaction codes
By Form 4 transaction code in selected period- M · Option exercise · dominant8 · 67%
- S · Open-market sells4 · 33%
Activity by reported role
A joint filing can contribute to multiple roles- Chief financial officer · dominant3 · 25%
- CMO3 · 25%
- COO3 · 25%
- SR3 · 25%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (4)Reported Holdings After
Separated by insider, security, and ownership typeThese are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redTop insiders
By absolute net value across the selected period- WM-$54.0k
- KM-$35.5k
- GI-$14.2k
- WE-$14.2k
Recent filing activity
Most recent 12 transactions · color = transaction codeFiling detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
No filing-only signal badges matched this period.
RXST transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| RXST | Kurtz Ronald M MD | CMO | exercise | 13.4k | $0 | M | — | — | 09/03 | 08/31 |
| RXST | Kurtz Ronald M MD | CMO | sale | 5.09k | -$3.54M | S | — | — | 09/03 | 09/02 |
| RXST | Kurtz Ronald M MD | CMO | exercise | 13.4k | — | M | — | — | 09/03 | 08/31 |
| RXST | Wilterding Mark | CFO | exercise | 20.4k | $0 | M | — | — | 09/03 | 08/31 |
| RXST | Wilterding Mark | CFO | sale | 7.76k | -$5.40M | S | — | — | 09/03 | 09/02 |
| RXST | Wilterding Mark | CFO | exercise | 20.4k | — | M | — | — | 09/03 | 08/31 |
| RXST | Goldshleger Ilya | COO | exercise | 5.37k | $0 | M | — | — | 09/03 | 08/31 |
| RXST | Goldshleger Ilya | COO | sale | 2.04k | -$1.42M | S | — | — | 09/03 | 09/02 |
| RXST | Goldshleger Ilya | COO | exercise | 5.37k | — | M | — | — | 09/03 | 08/31 |
| RXST | Weinberg Eric | SR | exercise | 5.37k | $0 | M | — | — | 09/03 | 08/31 |
| RXST | Weinberg Eric | SR | sale | 2.04k | -$1.42M | S | — | — | 09/03 | 09/02 |
| RXST | Weinberg Eric | SR | exercise | 5.37k | — | M | — | — | 09/03 | 08/31 |
RxSight, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at RxSight, Inc.?
Kurtz Ronald M MD, Wilterding Mark, Goldshleger Ilya, Weinberg Eric.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Kurtz Ronald M MD reported a sale on Sep 02, 2026 valued at $3.54M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $117,951.12. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.